Toggle navigation
HOME
NEWSFEEDS
Healthcare Industry News
Medical Devices
Biopharmaceuticals
Diagnostics
Cardiology
Interventional
Neuro
Oncology
Orthopaedic
Surgery
People
Distribution
FDA Actions
Regulatory (INTL)
Mergers & Acquisitions
Venture Capital
INDEPENDENT REPS
For MANUFACTURERS:
Find Reps NOW
Post Your Rep Opportunity
Not sure? Let us help!
For REPS and DISTRIBUTORS:
Not in FindReps? Contact us!
ISR REGISTRY:
Independent Sales Reps - USA
Not a MEMBER Yet?
Join HSMN
FORUMS
Independent Sales Reps & Distributors
The Network Bulletin Board
Getting Started in Medical Sales
Show All Forums
RESOURCES
FindReps®
Help / FAQs
INDUSTRY LINKS:
Medical Device Companies
Biopharmaceutical Companies
Professional Organizations
Government & Regulatory
Products & Services
Venture Capital
MEMBERS
Join HSMN
Forgot Username / Password
Help / FAQs
PASSWORD REQUIRED:
Company Links Listing (Manufacturers)
Products & Services Listing (Vendors)
Post in Forums
Renew Membership
Change Password
Update Contact Info
Something else? - Contact Us
ABOUT
About HSMN
Membership Info
FindReps®
Join HSMN
Help / FAQs
Submit News Release
Info for Advertisers
Contact Us
Searching News Database:
eFFECTOR Therapeutics
HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals
Venture Capital
Personnel
HSMN NewsFeed - 24 Jul 2017
eFFECTOR Therapeutics Completes $38.6 Million Series C Financing
Biopharmaceuticals
Oncology
Venture Capital
Personnel
HSMN NewsFeed - 19 Feb 2016
eFFECTOR Therapeutics Increases its Series B Financing Round to $56M
Biopharmaceuticals
Oncology
Venture Capital
Personnel
HSMN NewsFeed - 22 Dec 2015
eFFECTOR Therapeutics Raises $40 Million Series B Financing
Biopharmaceuticals
Oncology
Venture Capital
HSMN NewsFeed - 15 Dec 2015
eFFECTOR Therapeutics Appoints Alana McNulty Chief Financial Officer
Biopharmaceuticals
Oncology
Personnel
HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals
Venture Capital
Personnel
HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
Diagnostics
Personalized Medicine
Personnel
Return to NewsFeed
